5 simple steps for targeting a £1,000,000 SIPP

Through regular contributions and careful monitoring, investors can target a seven-figure long-term SIPP to improve their retirement quality of life.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A senior group of friends enjoying rowing on the River Derwent

Image source: Getty Images

Leveraging the power of a Self-Invested Personal Pension (SIPP) is one of the best ways to start building retirement wealth in the stock market. And looking at the latest data from the Office for National Statistics, it’s a step that many Britons may need to consider.

The average pension savings among 60-year-olds is £228,200 for men and £152,600 for women. Yet following the 4% withdrawal rule, that’s barely enough to generate the £14,400 recommended by the Pensions and Lifetime Savings Association to maintain a minimum retirement lifestyle, let alone a moderate or comfortable one.

With that in mind, let’s explore how investors can leverage a SIPP to try and build a £1m pension pot.

How to start

  1. Open a SIPP
  2. Deposit capital regularly
  3. Research investment opportunities
  4. Buy and hold for the long run
  5. Monitor and review

Different SIPP providers charge different fees, and it’s important to compare to find the most suitable platform. It’s also essential to regularly allocate money from a monthly paycheque to a SIPP so there’s capital available to buy quality shares.

Researching investment opportunities is where a lot of hiccups can occur. And for investors who don’t have the time, knowledge, or interest in picking individual stocks, an index fund might be a more suitable approach.

Once the investment decisions have been made, it’s just a matter of executing the trades and holding on for the long run. But of course, investors need to keep their fingers on the pulse to make sure their investment thesis isn’t slowly breaking.

Aiming for a million

Thanks to the tax relief provided by a SIPP, a lot of capital can be built quickly. For example, let’s say an investor’s contributing £500 a month into their pension pot. After tax relief, they could have anywhere between £625 and £1,100, depending on their income tax bracket.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Given enough time, it’s not that difficult to turn £625 a month into £1m. For example, the FTSE 100 has historically provided an average annual return of 8%. And investing £625 a month at this rate would reach £1m within 31 years.

But with stock picking, it’s possible to unlock an even higher return and shorten this journey considerably. Take AstraZeneca (LSE:AZN) as an example.

Today, the healthcare group’s one of the leading forces in cancer therapy, and novel drugs are being used worldwide. But 20 years ago, it was still an up-and-coming pharmaceutical business with a promising pipeline of medicines. Investors who saw the opportunity and capitalised on it have since enjoyed a 13% annualised return.

At this rate, the journey to a million would only take 23 years. And for those happy waiting for the full 30, their SIPPs could reach almost £3m!

Replicating this growth trajectory for new shareholders is likely going to be a challenge with AstraZeneca. After all, even with its impressive current pipeline of drugs, growth is much harder being a £165bn market-cap company. And all it takes is one unfavourable clinical trial result for a new blockbuster drug to send the share price plummeting.

However, it goes to show that by buying and holding quality businesses for the long run, investors can potentially reap tremendous returns.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing For Beginners

Experts think this penny stock could rise by 80% or more in the coming year

Jon Smith points out a penny stock that has the potential to soar this year if international expansion pays off,…

Read more »

Investing Articles

What next for Barclays shares, after this shock 15% slump?

What a tangled web we encounter when we look too deeply into the workings of the global banking sector. Barclays…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Will the Rolls-Royce share price rise 5% or 36% by this time next year?

Rolls-Royce's share price hit new heights after stunning full-year results on Thursday (26 February). Can the FTSE 100 firm keep…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Airtel Africa’s shares are up as others on the FTSE 100 plummet. What’s going on?

With yet another conflict starting in the Middle East, James Beard notes that investors are still buying Airtel Africa’s shares.…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Hot dates for dividend investors to mark in their March diaries

The year's stock market gains might be taking some edge off high yields, but UK dividend investors still have plenty…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Is it time to snap up Nvidia stock, after it fell 9% on Q4 results?

Nvidia makes a laughing stock of naysayers and their doom-and-gloom moods yet again, but the stock responds with a hefty…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

How much do you need in an ISA to generate a second income of £2,700 a month in 2050?

Ben McPoland highlights a 6%-yielding stock from the FTSE 100 index that could contribute towards an attractive second income.

Read more »

Iberian plane on runway
Investing Articles

Is this a once-in-a-decade chance to snap up my highest conviction UK share?

Harvey Jones is a big fan of this beaten-down UK share and reckons it offers some of the most exciting…

Read more »